Anastrozole Tablet
Product Images NDC 24979-725
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 24979-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
Figure 2 (Image 03)
Figure 3 (Image 04)
Figure 4 (Image 05)
This text appears to be a table displaying data related to a medical study comparing the effects of two treatments, Anastrozole and Tamoxifen. The data includes the number of patients at risk over a period of time as well as a note about improving the clarity of the Kaplan-Meier curves by truncating the vertical axis. The text provides insights into the progression of patients in the study over months and the comparison of the treatments.*
Figure 5 (Image 06)
Figure 6 (Image 07)
30's (Label30)
Each tablet of this medication contains 1 mg of Anastrozole, USP. It is advised to refer to the accompanying Prescribing Information for the usual dosage. This medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) and kept out of reach of children. This product is manufactured by Bora Pharmaceutical Services Inc. for TWi Pharmaceuticals USA, Inc. in Paramus, NJ. The package contains 30 tablets and is for prescription use only.*
90's (Label90)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.